Videos de Experimentos Relacionados
Mirando más allá de la incidencia del primer accidente cerebrovascular en la historia.
1Department of Neurology, Bispebjerg Hospital, Copenhagen, Denmark.
Lancet (London, England)
|July 11, 1998
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Human health risk assessment for exposures to 1,3-butadiene in the United States with input from an independent science advisory panel.
Regulatory toxicology and pharmacology : RTP·2025
Same author
Acute endovascular reperfusion treatment in patients with ischaemic stroke and large-vessel occlusion (Denmark 2011-2017).
European journal of neurology·2019
Same author
Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions.
Environmental and molecular mutagenesis·2018
Same author
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author
Thalamic infarcts: Effects on cerebral blood flow, metabolism, and neuropsychological function.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026